Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period

References

• van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–482. doi:10.1038/nrneurol.2014.12125023340
   PubMed Web of Science ®Google Scholar
• Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–133. doi:10.1159/00032471021422765
   PubMed Web of Science ®Google Scholar
• Delannoy A, Rudant J, Chaignot C, Bolgert F, Mikaeloff Y, Weill A. Guillain-Barre syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008–2013). J Peripher Nerv Syst. 2017;22(1):51–58. doi:10.1111/jns.1220227991707
   PubMed Web of Science ®Google Scholar
• Bak P. Guillain-Barre syndrome in a Danish county. Neurology. 1985;35(2):207–211.3969208
   PubMed Web of Science ®Google Scholar
• Congia S, Melis M, Carboni MA. Epidemiologic and clinical features of the Guillain-Barre’ syndrome in Sardinia in the 1961–1980 period. Acta Neurol (Napoli). 1989;11(1):15–20.2718810
   PubMedGoogle Scholar
• Winner SJ, Evans JG. Age-specific incidence of Guillain-Barre syndrome in Oxfordshire. Q J Med. 1990;77(284):1297–1304.2290923
   PubMedGoogle Scholar
• Govoni V, Granieri E, Casetta I, et al. The incidence of Guillain-Barre syndrome in Ferrara, Italy: is the disease really increasing?. J Neurol Sci. 1996;137(1):62–68.9120489
   PubMed Web of Science ®Google Scholar
• Cuadrado JI, de Pedro-Cuesta J, Ara JR, et al. Guillain-Barre syndrome in Spain, 1985–1997: epidemiological and public health views. Eur Neurol. 2001;46(2):83–91. doi:10.1159/00005076911528157
   PubMed Web of Science ®Google Scholar
• Jiang GX, de Pedro-Cuesta J, Fredrikson S. Guillain-Barre syndrome in south-west Stockholm, 1973–1991, 1. Quality of registered hospital diagnoses and incidence. Acta Neurol Scand. 1995;91(2):109–117.7785420
   PubMed Web of Science ®Google Scholar
• Shui IM, Rett MD, Weintraub E, et al. Guillain-Barre syndrome incidence in a large United States cohort (2000–2009). Neuroepidemiology. 2012;39(2):109–115. doi:10.1159/00033924822846726
   PubMed Web of Science ®Google Scholar
• Funch D, Holick C, Velentgas P, et al. Algorithms for identification of Guillain-Barre syndrome among adolescents in claims databases. Vaccine. 2013;31(16):2075–2079. doi:10.1016/j.vaccine.2013.02.00923474311
   PubMed Web of Science ®Google Scholar
• Huang WC, Lu CL, Chen SC. A 15-year nationwide epidemiological analysis of Guillain-Barre syndrome in Taiwan. Neuroepidemiology. 2015;44(4):249–254. doi:10.1159/00043091726088600
   PubMed Web of Science ®Google Scholar
• Statistik Denmark. 2018 Available from: http://www.statistikbanken.dk/statbank5a/default.asp?w=1536. Accessed 1024, 2018.
   Google Scholar
• Epidemiology FL. When an entire country is a cohort. Science (New York, NY). 2000;287(5462):2398–2399. doi:10.1126/science.287.5462.2398
   Google Scholar
• Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22–25. doi:10.1177/140349481038796521775345
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S9112526604824
   PubMed Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39(7 Suppl):30–33. doi:10.1177/140349481140148221775347
   PubMed Web of Science ®Google Scholar
• Al-Hakem H, Sindrup SH, Andersen H, et al. Guillain-Barre syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity. J Neurol. 2019;266(2):440–449.
   Web of Science ®Google Scholar
• Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol. 1998;44(5):780–788. doi:10.1002/ana.4104405129818934
   PubMed Web of Science ®Google Scholar
• Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol. 1990;27(Suppl):S21–S24.2194422
   PubMed Web of Science ®Google Scholar
• Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599–612. doi:10.1016/j.vaccine.2010.06.00320600491
   PubMed Web of Science ®Google Scholar
• Fokke C, van Den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain. 2014;137(Pt 1):33–43. doi:10.1093/brain/awt28524163275
   PubMed Web of Science ®Google Scholar
• Wakerley BR, Yuki N. Mimics and chameleons in Guillain-Barre and Miller Fisher syndromes. Pract Neurol. 2015;15(2):90–99. doi:10.1136/practneurol-2014-00093725239628
   PubMedGoogle Scholar
• Wilson EB. Probable Inference the law of succession, and statistical inference. J Am Stat Assoc. 1927;22(158):209–212. doi:10.1080/01621459.1927.10502953
   Google Scholar
• Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–351.10649300
   PubMed Web of Science ®Google Scholar
• Koobatian TJ, Birkhead GS, Schramm MM, Vogt RL. The use of hospital discharge data for public health surveillance of Guillain-Barre syndrome. Ann Neurol. 1991;30(4):618–621. doi:10.1002/ana.4103004181789689
   PubMed Web of Science ®Google Scholar
• Bogliun G, Beghi E. Validity of hospital discharge diagnoses for public health surveillance of the Guillain-Barre syndrome. Neurol Sci. 2002;23(3):113–117. doi:10.1007/s10072020003612391495
   PubMed Web of Science ®Google Scholar
• Lee CD, Jones TF. Hospital discharge database optimization in Guillain-Barre syndrome surveillance. Muscle Nerve. 2012;46(1):60–62. doi:10.1002/mus.2326122644597
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323–337. doi:10.1016/j.jclinepi.2004.10.01215862718
   PubMed Web of Science ®Google Scholar
• Rabie M, Nevo Y. Childhood acute and chronic immune-mediated polyradiculoneuropathies. Eur J Paediatr Neurol. 2009;13(3):209–218. doi:10.1016/j.ejpn.2008.04.00918585069
   PubMed Web of Science ®Google Scholar
• Statens Serum Institut. 2018 Available from: https://statistik.ssi.dk/. Accessed 1221, 2018.
   Google Scholar
• McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barre syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32(2):150–163. doi:10.1159/00018474819088488
   PubMed Web of Science ®Google Scholar
• Rees JH, Thompson RD, Smeeton NC, Hughes RA. Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry. 1998;64(1):74–77.9436731
   PubMed Web of Science ®Google Scholar
• Kaplan JE, Katona P, Hurwitz ES, Schonberger LB. Guillain-Barre syndrome in the United States, 1979–1980 and 1980–1981. Lack of an association with influenza vaccination. JAMA. 1982; 248(6):698–700.7097920
   PubMed Web of Science ®Google Scholar
• Loong TW. Understanding sensitivity and specificity with the right side of the brain. BMJ (Clini Res Ed). 2003;327(7417):716–719. doi:10.1136/bmj.327.7417.716
   PubMed Web of Science ®Google Scholar
• Roodbol J, de Wit MY, van Den Berg B, et al. Diagnosis of Guillain-Barre syndrome in children and validation of the Brighton criteria. J Neurol. 2017;264(5):856–861. doi:10.1007/s00415-017-8429-828251358
   PubMed Web of Science ®Google Scholar